FAQ

LicR protein, Bacillus subtilis

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2015
01219842015

Related topics

Related topics

2 relations

Broader (2)

Bacterial ProteinsTrans-Activators

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
LicR protein, Bacillus subtilis
Trans-Activators
Bacterial Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines
Increased expression of the epidermal growth factor receptor (EGFR) is observed in more than 90% of all head and neck squamous… (More)
  • table 1
  • table 2
Is this relevant?
2009
2009
Electronic Structure and Magnetic Properties of Spinel ${\hbox {LiCr}}_{2}{\hbox {O}}_{4}$: A ${\hbox {GGA}}+$ U Study
We performed the structure optimization followed by the calculation of electronic structure and magnetic properties on LiCr<sub>2… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
1985
1985
Monoclonal antibodies specific for subsets of epidermal keratins: biochemical and immunocytochemical characterization--applications in pathology and cell culture.
Keratin composition has been widely used as a biochemical marker of differentiation in normal epithelia, cell culture systems and… (More)
Is this relevant?
1984
1984
Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75.
With the object of generating specific cytotoxic agents, we have prepared covalent conjugates of the A-chains of ricin and of… (More)
Is this relevant?
1984
1984
Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Human lymphocytes from tumor-bearing patients and normal individuals have been fused with the NS-1 mouse myeloma line or the LICR… (More)
Is this relevant?